FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895927699> ?p ?o ?g. }

• W2895927699 endingPage "471" @default.
• W2895927699 startingPage "461" @default.
• W2895927699 abstract "Background: Trastuzumab is a monoclonal antibody against HER2-positive breast cancer. Despite improving the natural history of the disease, there is a number of patients who are resistant to it, whereas all patients will eventually develop resistance and disease will progress. Inconsistent preclinical data show that the IGF-R pathway may contribute to either de novo or acquired resistance to trastuzumab. Materials and Methods: In total, 227 trastuzumab-treated metastatic breast cancer patients were evaluated for IGF-1, IGF-1R, GLP-1R, Akt1, Akt2 Akt3 mRNA expression, and IGF-1Rα, IGF-1Rβ, IGF-2R protein expression. Results: Only 139 patients were truly HER2-positive by central assessment. Among HER2-positive patients, high Akt2 and GLP-1R mRNA expression showed a trend towards higher and lower risk of progression, respectively (HR=1.83, 95%CI=0.90-3.72, p=0.094 and HR=0.62, 95%CI=0.36-1.06, p=0.079), while high Akt1 and GLP-1R mRNA expression presented a trend towards unfavorable survival (HR=1.67, 95%CI=0.93-2.99, p=0.086 and HR=1.67, 95%CI=0.94-2.96, p=0.080). Among HER2-negative patients, high GLP-1R mRNA expression and negative stromal IGF-1Rβ protein expression showed a trend towards worse survival (HR=2.31, 95%CI=0.87-6.13, p=0.094 and HR=2.03, 95%CI=0.94-4.35, p=0.071, respectively). In the multivariate analyses, HER2-positive patients with high Akt1 and GLP-1R mRNA expression had a worse survival (HR=1.86, 95%CI=1.01-3.43, p=0.045 and HR=1.83, 95%CI=0.99-3.41, p=0.055, respectively). Conclusion: This study revealed a crosstalk between the IGF-R pathway and HER2. There was evidence that high Akt1 and GLP-1R mRNA expression might affect survival among HER2-positive metastatic breast cancer patients treated with trastuzumab." @default.
• W2895927699 created "2018-10-26" @default.
• W2895927699 creator A5002833730 @default.
• W2895927699 creator A5005181965 @default.
• W2895927699 creator A5005489735 @default.
• W2895927699 creator A5005730021 @default.
• W2895927699 creator A5007991935 @default.
• W2895927699 creator A5012112204 @default.
• W2895927699 creator A5015437737 @default.
• W2895927699 creator A5018787724 @default.
• W2895927699 creator A5021031807 @default.
• W2895927699 creator A5022893500 @default.
• W2895927699 creator A5026269698 @default.
• W2895927699 creator A5027646786 @default.
• W2895927699 creator A5030234379 @default.
• W2895927699 creator A5044696839 @default.
• W2895927699 creator A5046824508 @default.
• W2895927699 creator A5051365519 @default.
• W2895927699 creator A5057164541 @default.
• W2895927699 creator A5063290792 @default.
• W2895927699 creator A5088810830 @default.
• W2895927699 creator A5090216312 @default.
• W2895927699 date "2018-01-01" @default.
• W2895927699 modified "2023-10-06" @default.
• W2895927699 title "Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab" @default.
• W2895927699 cites W164886646 @default.
• W2895927699 cites W1966738468 @default.
• W2895927699 cites W1969345980 @default.
• W2895927699 cites W1973222840 @default.
• W2895927699 cites W1973378645 @default.
• W2895927699 cites W1976871031 @default.
• W2895927699 cites W1999070116 @default.
• W2895927699 cites W2001447115 @default.
• W2895927699 cites W2009218955 @default.
• W2895927699 cites W2015524046 @default.
• W2895927699 cites W2033795441 @default.
• W2895927699 cites W2037201627 @default.
• W2895927699 cites W2042482518 @default.
• W2895927699 cites W2055831769 @default.
• W2895927699 cites W2061360587 @default.
• W2895927699 cites W2061433554 @default.
• W2895927699 cites W2065988361 @default.
• W2895927699 cites W2067300576 @default.
• W2895927699 cites W2069707480 @default.
• W2895927699 cites W2076133821 @default.
• W2895927699 cites W2092294060 @default.
• W2895927699 cites W2094297159 @default.
• W2895927699 cites W2098544382 @default.
• W2895927699 cites W2109600717 @default.
• W2895927699 cites W2115759102 @default.
• W2895927699 cites W2117030318 @default.
• W2895927699 cites W2118521511 @default.
• W2895927699 cites W2118809819 @default.
• W2895927699 cites W2119975486 @default.
• W2895927699 cites W2120093145 @default.
• W2895927699 cites W2121514806 @default.
• W2895927699 cites W2122443183 @default.
• W2895927699 cites W2124919054 @default.
• W2895927699 cites W2130900820 @default.
• W2895927699 cites W2137853125 @default.
• W2895927699 cites W2141083924 @default.
• W2895927699 cites W2141393790 @default.
• W2895927699 cites W2145117379 @default.
• W2895927699 cites W2149773268 @default.
• W2895927699 cites W2163814095 @default.
• W2895927699 cites W2164654899 @default.
• W2895927699 cites W2169095558 @default.
• W2895927699 cites W2328264662 @default.
• W2895927699 cites W2397537304 @default.
• W2895927699 cites W2559323428 @default.
• W2895927699 cites W2607666115 @default.
• W2895927699 cites W2618728579 @default.
• W2895927699 cites W280448161 @default.
• W2895927699 cites W2982402876 @default.
• W2895927699 cites W2990803049 @default.
• W2895927699 cites W4239989216 @default.
• W2895927699 doi "https://doi.org/10.21873/cgp.20105" @default.
• W2895927699 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6299784" @default.
• W2895927699 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30343280" @default.
• W2895927699 hasPublicationYear "2018" @default.
• W2895927699 type Work @default.
• W2895927699 sameAs 2895927699 @default.
• W2895927699 citedByCount "9" @default.
• W2895927699 countsByYear W28959276992019 @default.
• W2895927699 countsByYear W28959276992020 @default.
• W2895927699 countsByYear W28959276992021 @default.
• W2895927699 countsByYear W28959276992022 @default.
• W2895927699 countsByYear W28959276992023 @default.
• W2895927699 crossrefType "journal-article" @default.
• W2895927699 hasAuthorship W2895927699A5002833730 @default.
• W2895927699 hasAuthorship W2895927699A5005181965 @default.
• W2895927699 hasAuthorship W2895927699A5005489735 @default.
• W2895927699 hasAuthorship W2895927699A5005730021 @default.
• W2895927699 hasAuthorship W2895927699A5007991935 @default.
• W2895927699 hasAuthorship W2895927699A5012112204 @default.
• W2895927699 hasAuthorship W2895927699A5015437737 @default.
• W2895927699 hasAuthorship W2895927699A5018787724 @default.
• W2895927699 hasAuthorship W2895927699A5021031807 @default.

• next